Pink Sheet is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Drugstore.com

This article was originally published in The Tan Sheet

Executive Summary

Shareholders lawsuit alleges firm violated securities law by selling common stock pursuant to e-tailer's IPO without disclosing some underwriters solicited and received "excessive and undisclosed" commissions from investors. Complaint filed June 27 in Manhattan federal court by Stull, Stull & Brody alleges existence of "laddering scheme" in which underwriters allocated shares to customers at IPO price of $18 in exchange for investors' agreement to purchase additional shares at progressively higher prices, thereby artificially inflating share price. Suit seeks damages on behalf of class of shareholders who purchased drugstore.com stock between July 28, 1999 and June 15. E-tailer declined comment
Advertisement

Topics

Advertisement
UsernamePublicRestriction

Register

PS092758

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel